News

SHERIDAN, WYOMING - November 13, 2025 - Dentsply Sirona is strengthening its long-term commitment to increasing oral-health access for U.S. veterans, deepening its partnership with Dental Lifeline Network (DLN) and activating employee-driven support initiatives across the country. The renewed collaboration aligns with the company's global sustainability strategy and reflects a growing corporate focus on social-impact programs that directly address care gaps in underserved populations.

Strengthening a Decades-Long Collaboration

SHERIDAN, WYOMING - November 13, 2025 - Heidelberger Druckmaschinen AG (HEIDELBERG) has delivered a notably stronger first half of fiscal year 2025/2026, reporting higher sales, sharply improved profitability and continued strategic momentum across its printing, packaging and technology businesses. The results signal renewed financial resilience as the company advances its transformation strategy amid ongoing macroeconomic pressure.

Sales Growth Across Core Markets

SHERIDAN, WYOMING - November 13, 2025 - Amperfied, the e-mobility subsidiary of Heidelberger Druckmaschinen AG (HEIDELBERG), has secured one of Germany's most significant corporate charging-infrastructure contracts of the year, taking over the migration and long-term operational management of Siemens Energy's nationwide EV charging network. The agreement positions Amperfied as a leading systems integrator for enterprise-scale charging operations as demand for reliable, multi-site electrification continues to accelerate.

SHERIDAN, WYOMING - November 13, 2025 - Dentsply Sirona and Rapid Shape have jointly advanced digital denture manufacturing by validating the Lucitone Digital Print Denture System across Rapid Shape's D50+, D90+ and PRO 20 3D printers. The collaboration expands access to high-strength printable denture materials and fully automated workflows, helping dental laboratories scale production as technician shortages and patient demand intensify globally.

A Major Expansion of Validated Digital Denture Workflows

SHERIDAN, WYOMING - November 13, 2025 - Teleste has completed a major upgrade to the main outdoor passenger information display at Helsinki Central Railway Station, bringing next-generation RGB LED technology to Finland's busiest transportation hub. The deployment enhances real-time communication for up to 300,000 daily travelers and strengthens Teleste's long-standing partnership with national traffic management authority Fintraffic.

SHERIDAN, WYOMING - November 13, 2025 - Dentsply Sirona celebrated two decades of its Global Clinical Case Contest (GCCC), honoring dental students who demonstrated exceptional restorative dentistry skills and a growing mastery of digital workflows. The anniversary event highlighted how the company continues to invest in early-career clinicians, raising global standards in esthetic and functional dentistry through hands-on education, mentorship and modern restorative technologies.

A Milestone Year for an International Training Platform

SHERIDAN, WYOMING - November 13, 2025 - ARCHITECT@WORK (A@W) will return to Messe Düsseldorf on December 3-4, 2025, with a sharpened focus on sustainable building and architectural transformation. The curated event, long regarded as a must-attend platform for specifiers, architects, and interior designers, is positioning its 9th Düsseldorf edition around the industry's most urgent mandate: repurposing, upgrading, and decarbonizing the built environment.

SHERIDAN, WYOMING - November 13, 2025 - Pfizer has completed its $7 billion acquisition of Metsera, securing a set of differentiated obesity and cardiometabolic candidates as regulatory momentum accelerates around metabolic disease innovation in the United States. The deal positions Pfizer at the center of one of the most politically scrutinized and fastest-growing therapeutic markets, as federal leaders push for expanded access and a stronger domestic pipeline in obesity care.

SHERIDAN, WYOMING - November 13, 2025 - As the TrumpRx platform approaches launch in early 2026, U.S. drugmakers are rolling out targeted direct-to-consumer pricing for a carefully chosen mix of dermatology, respiratory, cardiovascular, immunology, and metabolic products. While the discounts generate attention, analysts say their commercial impact varies sharply by drug class, revenue cycle, and therapeutic demand-revealing a strategic pattern rather than a broad affordability shift.

SHERIDAN, WYOMING - November 13, 2025 - Major pharmaceutical companies are rapidly rolling out direct-to-consumer (DTC) pricing programs ahead of the federal TrumpRx platform's debut in early 2026, signaling a shift in commercial strategy as manufacturers seek to bypass traditional intermediaries and regain control of how patients access branded therapies. Yet analysts warn that these channels-despite deep headline discounts-may offer only marginal financial relief to most patients and are unlikely to dent overall U.S. drug spending.